What one share of Vericel holds
Vericel Corporation is a leading provider of advanced therapies for the sports medicine and severe burn care markets. We have a highly differentiated portfolio of cell therapy and specialty biologic products that combines innovations in biology with medical technologies.
Vericel’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $5.83 |
|---|---|
| Profit | $0.46 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | $1.17 |
| Cash and investments | $2.45 |
| Book value | $7.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$17.97 | $0.04 | −$15.48 | — | $18.74 |
| 2010 | — | −$11.77 | $0.10 | −$12.30 | — | $11.95 |
| 2011 | — | −$10.18 | $0.53 | −$13.22 | — | −$6.71 |
| 2012 | — | −$16.25 | $0.13 | −$14.47 | — | −$14.66 |
| 2013 | — | −$6.95 | $0.01 | −$6.63 | — | $0.82 |
| 2014 | $2.47 | −$2.23 | $0.07 | −$2.25 | — | — |
| 2015 | $2.15 | −$0.97 | $0.10 | −$0.66 | — | $0.93 |
| 2016 | $2.35 | −$1.18 | $0.06 | −$0.92 | — | $0.78 |
| 2017 | $1.92 | −$0.52 | $0.05 | −$0.44 | — | $0.63 |
| 2018 | $2.26 | −$0.20 | $0.07 | −$0.08 | — | $2.35 |
| 2019 | $2.67 | −$0.22 | $0.06 | −$0.22 | — | $2.48 |
| 2020 | $2.63 | $0.06 | $0.06 | $0.32 | — | $2.93 |
| 2021 | $3.36 | −$0.16 | $0.17 | $0.45 | — | $3.64 |
| 2022 | $3.49 | −$0.35 | $0.16 | $0.21 | — | $4.07 |
| 2023 | $4.15 | −$0.07 | $0.42 | $0.32 | — | $4.72 |
| 2024 | $4.59 | $0.20 | $1.24 | −$0.11 | — | $5.88 |
| 2025 | $5.30 | $0.32 | $0.52 | $0.47 | — | $7.01 |
Common questions about Vericel
How much does one share of Vericel earn?
Over the last 12 months, each share of Vericel earned $0.46 of profit on $5.83 of sales, keeping about 8¢ of every $1 (profit margin).
Does Vericel pay a dividend?
Vericel didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Vericel’s book value per share?
Vericel’s book value is $7.23 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Vericel have?
Each share of Vericel has $2.45 of cash and investments, as of June 30, 2026.
What is Vericel’s free cash flow per share?
$1.17 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Vericel bought back shares?
Vericel’s share count rose about 5734% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.